![]() |
|
Graduate (1991) PhD (Complutense U., Madrid, 1995). Associate professor (1997) and full professor (2002) in Applied Mathematics at the Mathematics Department of the University of Castilla-La Mancha. Founding (2007-2012) and current (2016-) director of the Institute of Applied Mathematics in Science and Engineering (UCLM). Director of the department of mathematics (2005-2008, 2012-2016) at the same university. He has published more than 170 ISI-indexed research papers with 5800 citations and has an H-index of 40 (web of Science). He is editor in chief of "Physica D" and serves in the editorial boards of "Cancers", "European Radiology" and other journals. He is a member of the scientific committees of the Spanish Royal Society of Mathematics, the board of "Mathematical Action against coronavirus". He is a manager of Applied Mathematics at the Spanish National Research Agency. He has been a member of the Marie Curie evaluation committee and of many international project evaluation boards in oncology and/or applied mathematics in France, UK, Poland, Austria, Romania, Cyprus, Latvia, Spain, etc.
His main field of research is the application of mathematical modeling to oncology and more specifically to brain tumors, metastasis, cellular immunotherapies, biomarkers, medical images, lymphomas, leukaemias, prostate cancer, etc. In this field he leads several projects funded by public institutions, private foundations such as the James S. Mc. Donnell Foundation and pharmaceutical companies such as NOVARTIS. |
-
18F-Fluorocholine PET/CT in the prediction of molecular subtypes and prognosis for gliomas.
Clinical Nuclear Medicine 44(10) e548-e558 (2019).
A.M. Garcia Vicente, J. Perez-Beteta, M. Amo-Salas, F.J. Pena Pardo, M. Villena, H. Sandoval, M. Mollejo, R. Barbella, C.J. Klein, J.M. Borras, A.M. Soriano, V.M. Pérez-García -
Applied Mathematics in Oncology. How can we help cancer patients?
ICIAM Valencia Intelligencer (2019) 72-82
V.M. Pérez-García, S. Fitzpatrick, M. Pesic, P. Schucht, J.M. Sepúlveda, F.M. Vallette -
Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas.
PLOS Computational Biology 15(7) (2019) e1006778
V.M. Pérez-García, L.E. Ayala-Hernández, J. Belmonte-Beitia, P. Schucht, M. Murek, A. Raabe -
Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer.
Rev Esp Med Nucl Im Mol 38(5) 290-297 (2019)
M.J. Tello-Galán, A.M. García Vicente, J. Pérez-Beteta, M. Amo-Salas, G.A. Jiménez Londoño, F.J. Pena Pardo, A. Soriano, V.M. Pérez García -
Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcome
Journal of the Royal Society Interface 20190195 (2019)
G. Lorenzo, V.M. Pérez-García, Alfonso Mariño, L.A. Pérez Romasanta, Alessandro Reali, H. Gómez -
Modulation of antioxidant potential with coenzyme Q10 suppressed invasion of temozolomide resistant rat glioma in vitro and in vivo
Oxidative Medicine and Cellular Longevity 2019, 3061607 (2019)
S. Stojkovic, A. Podolski-Renic, J. Dinic, T. Stankovic, M. Jovanovic, S. Hadžic, J.M. Ayuso, M. Virumbrales-Muñoz, L.J. Fernández, I. Ochoa, V.M. Perez-Garcia, M. Pešic -
Morphologic features on MR imaging classify multifocal glioblastomas in different prognostic groups
American Journal of Neuro-radiology 40 (4) 634-640 (2019).
J. Pérez-Beteta, D. Molina, M. Villena, M. Rodríguez, C. Velásquez, J. Martino, B. Meléndez, A.R. de Lope, R. Morcillo, J. Sepúlveda, A. Hernández, A. Ramos, J. Barcia, P. Lara, D. Albillo, A. Revert, E. Arana, V.M. Pérez-Garcia -
Morphological MRI-based features provide pretreatment and post-surgery survival prediction in glioblastoma
European Radiology 29(4) 1968-1977 (2019)
J. Pérez-Beteta, D. Molina-García, A. Martínez-González, M. Amo, A. Henares-Molina, B. Luque, E. Arregui, M. Calvo, J.M.Borrás, J. Martino, C. Velasquez, B. Meléndez, A.R. de Lope, R. Moreno, J.A. Barcia, B. Asenjo, M. Benavides, I. Herruzo, P.C. Lara, R. Cabrera, D. Albillo, M. Navarro, L.A. Pérez-Romasanta, A. Revert, E. Arana, V.M. Pérez-García -
Prognostic models based on imaging findings in glioblastoma: Human versus Machine
Scientific Reports 9:5982 (2019)
D. Molina-García, L. Vera, J. Pérez-Beteta, E. Arana, V.M. Pérez-García
- Early identification of relapse and treatment optimization in acute lymphoblastic leukaemias through mathematical modelling and discriminant analysis
Junta de Andalucía (2020 - 2023) - Improving cell therapies in neuroblastoma through mathematical modelling
NeN Association (2020 - 2023) - Mathematical models in Oncology
Ministerio de Ciencia e Innovación (Spain) (2020 - 2023) - Mathematical models of tumor growth and response to therapies
Junta de Comunidades de Castilla-La Mancha (2018 - 2021) - Therapy Optimization in Glioblastoma: An integrative human data-based approach using mathematical models (Stage II)
James S. Mc. Donnell Foundation (USA) (2018 - 2021)

Graduate (1991) PhD (Complutense U., Madrid, 1995). Associate professor (1997) and full professor (2002) in Applied Mathematics at the Mathematics Department of the University of Castilla-La Mancha. Founding (2007-2012) and current (2016-) director of the Institute of Applied Mathematics in Science and Engineering (UCLM). Director of the department of mathematics (2005-2008, 2012-2016) at the same university. He has published more than 170 ISI-indexed research papers with 5800 citations and has an H-index of 40 (web of Science). He is editor in chief of "Physica D" and serves in the editorial boards of "Cancers", "European Radiology" and other journals. He is a member of the scientific committees of the Spanish Royal Society of Mathematics, the board of "Mathematical Action against coronavirus". He is a manager of Applied Mathematics at the Spanish National Research Agency. He has been a member of the Marie Curie evaluation committee and of many international project evaluation boards in oncology and/or applied mathematics in France, UK, Poland, Austria, Romania, Cyprus, Latvia, Spain, etc.
His main field of research is the application of mathematical modeling to oncology and more specifically to brain tumors, metastasis, cellular immunotherapies, biomarkers, medical images, lymphomas, leukaemias, prostate cancer, etc. In this field he leads several projects funded by public institutions, private foundations such as the James S. Mc. Donnell Foundation and pharmaceutical companies such as NOVARTIS. |
- 18F-Fluorocholine PET/CT in the prediction of molecular subtypes and prognosis for gliomas.
Clinical Nuclear Medicine 44(10) e548-e558 (2019).
A.M. Garcia Vicente, J. Perez-Beteta, M. Amo-Salas, F.J. Pena Pardo, M. Villena, H. Sandoval, M. Mollejo, R. Barbella, C.J. Klein, J.M. Borras, A.M. Soriano, V.M. Pérez-García - Applied Mathematics in Oncology. How can we help cancer patients?
ICIAM Valencia Intelligencer (2019) 72-82
V.M. Pérez-García, S. Fitzpatrick, M. Pesic, P. Schucht, J.M. Sepúlveda, F.M. Vallette - Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas.
PLOS Computational Biology 15(7) (2019) e1006778
V.M. Pérez-García, L.E. Ayala-Hernández, J. Belmonte-Beitia, P. Schucht, M. Murek, A. Raabe - Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer.
Rev Esp Med Nucl Im Mol 38(5) 290-297 (2019)
M.J. Tello-Galán, A.M. García Vicente, J. Pérez-Beteta, M. Amo-Salas, G.A. Jiménez Londoño, F.J. Pena Pardo, A. Soriano, V.M. Pérez García - Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcome
Journal of the Royal Society Interface 20190195 (2019)
G. Lorenzo, V.M. Pérez-García, Alfonso Mariño, L.A. Pérez Romasanta, Alessandro Reali, H. Gómez - Modulation of antioxidant potential with coenzyme Q10 suppressed invasion of temozolomide resistant rat glioma in vitro and in vivo
Oxidative Medicine and Cellular Longevity 2019, 3061607 (2019)
S. Stojkovic, A. Podolski-Renic, J. Dinic, T. Stankovic, M. Jovanovic, S. Hadžic, J.M. Ayuso, M. Virumbrales-Muñoz, L.J. Fernández, I. Ochoa, V.M. Perez-Garcia, M. Pešic - Morphologic features on MR imaging classify multifocal glioblastomas in different prognostic groups
American Journal of Neuro-radiology 40 (4) 634-640 (2019).
J. Pérez-Beteta, D. Molina, M. Villena, M. Rodríguez, C. Velásquez, J. Martino, B. Meléndez, A.R. de Lope, R. Morcillo, J. Sepúlveda, A. Hernández, A. Ramos, J. Barcia, P. Lara, D. Albillo, A. Revert, E. Arana, V.M. Pérez-Garcia - Morphological MRI-based features provide pretreatment and post-surgery survival prediction in glioblastoma
European Radiology 29(4) 1968-1977 (2019)
J. Pérez-Beteta, D. Molina-García, A. Martínez-González, M. Amo, A. Henares-Molina, B. Luque, E. Arregui, M. Calvo, J.M.Borrás, J. Martino, C. Velasquez, B. Meléndez, A.R. de Lope, R. Moreno, J.A. Barcia, B. Asenjo, M. Benavides, I. Herruzo, P.C. Lara, R. Cabrera, D. Albillo, M. Navarro, L.A. Pérez-Romasanta, A. Revert, E. Arana, V.M. Pérez-García - Prognostic models based on imaging findings in glioblastoma: Human versus Machine
Scientific Reports 9:5982 (2019)
D. Molina-García, L. Vera, J. Pérez-Beteta, E. Arana, V.M. Pérez-García
- Early identification of relapse and treatment optimization in acute lymphoblastic leukaemias through mathematical modelling and discriminant analysis
Junta de Andalucía (2020 - 2023) - Improving cell therapies in neuroblastoma through mathematical modelling
NeN Association (2020 - 2023) - Mathematical models in Oncology
Ministerio de Ciencia e Innovación (Spain) (2020 - 2023) - Mathematical models of tumor growth and response to therapies
Junta de Comunidades de Castilla-La Mancha (2018 - 2021) - Therapy Optimization in Glioblastoma: An integrative human data-based approach using mathematical models (Stage II)
James S. Mc. Donnell Foundation (USA) (2018 - 2021)